Sarah Jessica Parker is ceasing her relationship with drug company Mylan after it raised the price of their life-saving EpiPen to $500. Parents are increasingly feeling the pinch as they fill prescriptions so their children have the life-saving devices at school as well as home. Va. – Mylan head Heather Bresch’s father, wasn’t so harsh.
Advertisement
The pharmacy benefits manager trade group, the Pharmaceutical Care Management Association, also weighed in on the subject, saying Mylan was the latest drugmaker trying to reframe a pricing problem into a coverage problem. Thursday, it upped that discount to $300, about a 50% discount off the list price. It doubled the limit for eligibility for its patient assistance program, so a family of four making up to $97,200 would pay nothing out of pocket.
Responding to Bresch’s interview, Fox Business News analyst Liz Clayman said Thursday on MetroNews “Talkline” Bresch completely try to deflect the controversy onto insurance companies and Obamacare. She said the remaining $334 goes through a number of middle men who get their cut.
While Mylan is yet to respond to Parker’s criticism directly, the company’s CEO Heather Bresch said “no-one is more frustrated than me” in response to the backlash and partly attributed the price hike to “the United States healthcare crisis” saying the “system is broken”.
The Sears say have this message for drug maker Mylan.
She just hopes prices will start going down, as her kids grow up.
Mylan is boosting programs to help patients pay for its EpiPen emergency allergy treatment after heated criticism about an average cost that has soared over the past decade.
“I have patients who refuse to pick up the medication cause their co-pay is so high”.
The Sex and the City star became a paid spokesperson for Mylan, the pharmaceutical company behind the EpiPen, after using the emergency device when she realised her now-13-year-old son James Wilkie was deathly allergic to peanuts.
Advertisement
While the company’s efforts to lower costs to make EpiPens more affordable is a step in the right direction, much more still needs be done, addressed, and reformed to make healthcare accessible for everyone. Many other drugmakers also routinely raise prices of their prescription drugs by 10 percent or more each year, and US legislation is needed to prevent such “price spikes”, he added.
